近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
代表性论文：
1.TanSY,DuanH,XunTR,CiW,QiuJY,YuF,ZhaoXY,WuLX,LiL,LuL,JiangSB,LiuSW*.HIV-1ImpairsHumanRetinalPigmentEpithelialBarrierFunction:PossibleAssociationwiththePathogenesisofHIV-associatedRetinopathy.LaboratoryInvestigation.2014,inpress.
2.TanSY,LiL,LuL,PanCG,LuH,OksovY,TangXJ,JiangSB*,LiuSW*.PeptidesDerivedfromHIV-1gp120Co-receptorBindingDomainFormAmyloidFibrilsandEnhanceHIV-1Infection.FEBSLetters.2014,inpress.
3.YuF,LuL,LiuQ,YuXW,WangLL,HeE,ZouP,DuLY,SandersRW,LiuSW*,JiangSB*.ADS-J1inhibitsHIV-1infectionandmembranefusionbytargetingthehighlyconservedpocketinthegp41NHR-trimer.BiochimicaetBiophysicaActa-Biomembrane,2014;1838(5):1296-1305.
4.GuCP,YuFL,YuL,HeXY,ZhongDS,HeLG,LvLY,XieL,LiuSW*.AnovelsyntheticdibenzocyclooctadienelignananalogXLYF-104-6attenuateslipopolysaccharide-inducedinflammatoryresponseinRAW264.7macrophagecellsandprotectsBALB/cmicefromsepsis.EuropeanJournalofPharmacology,2014;729(1):22-29
5.ZhouZZ,GuCP,DengYH,YanGH,LiXF,YuL,ChenWH*,LiuSW*.Synthesis,selectivecytotoxicitiesandprobablemechanismofactionof7-methoxy-3-arylflavone-8-aceticacids.Bioorganic&MedicinalChemistry,2014;22(5):1539-1547
6.HeLG,LiXL,ZengXZ,DuanH,WangS,LeiLS,LiXJ*,LiuSW*.SinomenineinducesapoptosisinRAW264.7cell-derivedosteoclastsviacaspase-3activation.ActaPharmacologicaSinica.2014;35(2):203-10
7.YuFL,HeXY,GuCP,OhkoshiE,WangLT,LaiCY,YuL,WangSB,Morris-NatschkeSL,LeeKX,LiuSW*,XiL*.DiscoveryofNovelAntitumorDibenzocyclooctatraeneDerivativesandRelatedBiphenylsasPotentInhibitorsofNF-kappaBSignalingPathway.Bioorganic&MedicinalChemistry,2014;22(1):325-33.
8.ZhuQH,HuangL,SuJR,LiuSW*.Asensitiveandvisiblefluorescence-turn-onprobefortheCMCdeterminationofionicsurfactants.ChemicalCommunications,2014;50(9):1107-1109
9.YuL,LiuSW*.AutophagycontributestomodulatingthecytotoxicitiesofBcl-2homologydomaim-3mimetics.SeminarsinCancerBiology,2013,23(6PtB):553-60
10.SongDS,XuHH*,LiuSW*.TheoreticalStudiesoftheInteractionsbetweenHemagglutininoftheInfluenzaVirusanditsSmallMoleculeLigands.JournalofMolecularModeling,2013;19(12):5561-8.
11.QiuJ,AshkenaziA,LiuS,ShaiY.StructuralandFunctionalPropertiesoftheMembranotropicHIV-1Gp41LoopRegionareModulatedbyitsIntrinsicHydrophobicCore.JournalofBiologicalChemistry.2013,288(40):29143-29150
12.LiXJ,HeLG,HuYP,DuanH,LiXL,TanSY,ZouM,GuCP,YuL,XuJK,LiuSW*.SinomeninesuppressesosteoclastformationandMycobacteriumtuberculosisH37Ra-inducedbonelossbymodulatingRANKLsignalingpathways.PLoSOne,2013,8(9):e74274
13.HuangL,SuJR,ZhongDS,LiuRY,WangHB,YuL,ZhuQH*,LiuSW*.Copper-InducedFluorescenceEnhancementandParticle-SizeDecrease.RSCAdvances,2013,3(32),13286-13292
14.LvLY,ZhengSC,CaiXT,ChenZP,ZhuQH*,LiuSW*.Developmentoffour-componentsynthesisoftetra-andpentasubstitutedpolyfunctionaldihydropyrroles:freepermutationandcombinationofaromaticandaliphaticAmines.ACSCombinatorialScience.2013;15(4):183-92
15.TanSY,LuL,LiL,LiuJX,OksovY,LuL,JiangSB*,LiuSW*.Polyanioniccandidatemicrobicidesacceleratetheformationofsemen-derivedamyloidfibrilstoenhanceHIV-1infection.PLoSOne,2013,8(3):e59777IF:3.730
16.LiL,QiuJY,LuL,AnSL,QiaoP,JiangSB,LiuSW*.3-Hydroxyphthalicanhydride-modifiedhumanserumalbuminasamicrobicidecandidateinhibitsHIVinfectionbyblockingviralentry.JournalofAntimicrobialChemotherapy.2013;68(3):573-576
17.YangJ,LiMM,ShenXT,LiuSW*.InfluenzaAvirusentryinhibitorstargetingthehemagglutinin.Viruses,2013;5(1):352-373.
18.BaiY,XueHF,WangK,CaiLF,QiuJY,BiSY,LaiLH,ChenMS,LiuSW*,LiuKL*.CovalentfusioninhibitorstargetingHIV-1gp41deeppocket.AminoAcids,2013;44(2):701-713
19.ChenMH,YuL,GuCP,ZhongDS,WuSG,LiuSW*.Celecoxibantagonizesthecytotoxiceffectofcisplatininhumangastriccancercellsbydecreasingintracellularcisplatinaccumulation.CancerLetters,2013;329:189-196
20.ZhuQH,HuangL,ChenZP,ZhengSC,LvLY,ZhuZB,CaoDL,JiangHF*,LiuSW*.ANovelSeriesofC-6UnsubstitutedTetrahydropyrimidines:ConvenientOne-PotChemoselectiveSynthesis,Aggregation-InducedandSize-IndependentEmissionCharacteristics.Chemistry:AEuropeanJournal.2013;19(4):1268-1280
21.YangJ,LiL,JinH,TanSY,QiuJY,YangL,DingYQ,JiangZH,JiangSB,LiuSW*.VaginalgelformulationbasedontheaflavinderivativesasamicrobicidetopreventHIVsexualtransmission.AIDSResearchandHumanRetroviruses,2012,28(11):1498-508
22.ZhuZB,LiRM,XiaoGK,ChenZP,YangJ,ZhuQH,LiuSW*.Design,synthesisandstructure-activityrelationshipofnovelinhibitorsagainstH5N1hemagglutinin-mediatedmembranefusion.EuropeanJournalofMedicinalChemistry.2012,57:211-6.
23.LiRM,SongDS,ZhuZB,XuHH,LiuSW*.AninducedpocketforthebindingofpotentfusioninhibitorCL-385319withH5N1influenzavirushemagglutinin.PLoSOne,2012,7(8):e41956
24.ZhuQH,GaoLX,ChenZP,ZhengSC,SuHF,LiJ*,JiangHF*,LiuSW*.Anovelclassofsmall-moleculecaspase-3inhibitorspreparedbymulticomponentreactions.EuropeanJournalofMedicinalChemistry.2012,54:232-238.
25.ZengYL,LiW,LiJT,WangJJ,ZhouB,ZhangJ,LiuSW*,WuYS,HouJL,ZhouYP*.HepatitisCvirusaminoacidsequencediversitycorrelateswiththeoutcomeofcombinedinterferon/ribavirintherapyinChinesepatientswithchronichepatitisC.ArchiveofVirology.2012,157(1):1113-1121.
26.JiaQY,JiangXF,YuF,QiuJY,KangXY,CaiLF,LiL,ShiWG,LiuSW*,JiangSB*,LiuKL*.ShortcyclicpeptidesderivedfromtheC-terminalsequenceofα1-antitrypsinexhibitsignificantanti-HIV-1activity.Bioorganic&MedicinalChemistryLetters.2012,22(7):2393-5.
27.LiXJ,HuYP,HeLG,WangS,ZhouH,LiuSW*.IcaritininhibitsTcellactivationandprolongsskinallograftsurvivalinmice.InternationalImmunopharmacology.2012;13(1):1-7.
28.YangJ,LiL,TanSY,JinH,QiuJY,MaoQC,LiRM,XiaCL,JiangZH,JiangSB,LiuSW*.AnaturaltheaflavinspreparationinhibitsHIV-1infectionbytargetingtheentrystep:potentialapplicationsforpreventingHIV-1infection.Fitoterapia,2012;83(2):348-355
29.YuL,ChenMH,LiZJ,WenJ,FuJH,GuoG,JiangY,WuSW,ChoCH,LiuSW*.Celecoxibantagonizesthecytotoxicityofcisplatininhumanesophagealsquamouscellcarcinomacellsbyreducingintracellularcisplatinaccumulation.MolecularPharmacology,2011;79(3):608-617
30.LiL,TanSY,LuH,LuL,YangJ,JinH,LiuSW*,JiangS*.Combinationsof3-HydroxyphthalicAnhydride-modifiedOvalbuminwithAntiretroviralDrug-basedMicrobicideCandidatesDisplaySynergisticandComplementaryEffectsagainstHIV-1Infection.JournalofAcquiredImmuneDeficiencySyndromes,2011;56(5):384-392
31.LiuSW*,LiRM,ZhangRT,ChanC,XiBM,ZhuZB,YangJ,PoonV,ZhouJ,ChenM,MünchJ,KirchhoffF,PleschkaS,HaarmannT,DietrichU,PanCG,DuLY,JiangSB,ZhengBJ*.CL-385319inhibitsH5N1avianinfluenzaAvirusinfectionbyblockingviralentry.EuropeanJournalofPharmacology,2011;660(2-3):460-467
32.ShangSF,TanSY,LiKB,WuJ,LinHN,LiuSW*,DengYQ*.Glu659LeusubstitutionofrecombinantHIVfusioninhibitorC52LinducessolubleexpressioninE.coliwithequivalentanti-HIVpotency.ProteinEngineering,Design&Selection,2011;24(7):545-551
33.XiaCL,LuoDX,YuXL,JiangSB*,LiuSW*.HIV-associateddementiaintheeraofhighlyactiveantiretroviraltherapy(HAART).MicrobesandInfection,2011;13:419-425
34.ZhouZZ,ZouM,ZhouJ,ZhouCQ,DengYH,ChenMH,GuCP,JiangZH,ChenWH*,LiuSW*.Synthesis,CytotoxicitiesandDNA-BindingAffinitiesofBenzofuran-3-olsandTheirFusedAnalogs.ChemicalandPharmaceuticalBulletin,2011;59(8):1057-1061.
35.LiL,QiaoP,YangJ,TanS,LuH,ZhangX,ChenX,WuS,JiangS*,LiuS*.Maleicanhydride-modifiedchickenovalbuminasaneffectiveandinexpensiveanti-HIVmicrobicidecandidateforpreventionofHIVsexualtransmission.Retrovirology,2010,7(1):37
36.LiL,HeL,TanS,GuoX,LuH,QiZ,PanC,AnX,JiangS*,LiuS*.3-HydroxyphthalicAnhydride-modifiedChickenOvalbuminExhibitsPotentandBroadAnti-HIV-1Activity:aPotentialMicrobicideforPreventingSexualTransmissionofHIV-1.AntimicrobialAgentsandChemotherapy,2010,54(5):1700-1711
37.WangHT,QiZ,GuoA,MaoQC,LuH,AnXL,XiaCL,LiXJ,DebnathAK,WuSG,LiuSW*,JiangSB*.ADS-J1inhibitsHIV-1entrybyinteractingwiththegp41pocketregionandblockingthefusion-activegp41coreformation.AntimicrobialAgentsandChemotherapy,2009;53(12):4987-4998
38.DuLY,HeYX,ZhoYS,LiuSW,ZhengBJ,JiangSB.ThespikeproteinofSARS-CoV—atargetforvaccineandtherapeuticdevelopment.NatureReviewofMicrobiology,2009;7(3):226-236
39.LiuSW*,JingW,ChengB,LuH,SunJ,YanX,NiuJ,FarmarJ,WuS,JiangS.HIVgp41c-terminalheptadrepeatcontainsmulti-functionaldomains:relationtomechanismsofactionofanti-HIVpeptides.JournalofBiologicalChemistry,2007;282(13):9612-9620
40.LiuSW,WuSG,JiangSB.HIVentryinhibitorstargetinggp41:frompolypeptidestosmall-moleculecompounds.CurrentPharmaceuticalDesign,2007;13(2):143-162.
41.JiangSB,LiuSW,StoneA.ChinaneedssafeandeffectivemicrobicidesforpreventingthesexualtransmissionofHIV.LancetInfectiousDiseases,2006;6(11):681-682
42.LiuSW,LuH,NiuJ,XuY,WuS,JiangS.DifferentfromtheHIVfusionInhibitorC34,theanti-HIVdrugFuzeon(T-20)inhibitsHIV-1entrybytargetingmultiplesitesingp41andgp120.JournalofBiologicalChemistry,2005;260(12):11259-11273
43.LiuSW,LuH,NeurathAR,JiangS.Combinationofcandidatemicrobicidescelluloseacetate1,2-benzenedicarboxylateandUC781resultsinsynergisticandcomplementaryeffectsagainsthumanimmunodeficiencyvirustype1infection.AntimicrobialAgentsandChemotherapy,2005;49(5):1830-1836
44.LiuSW,LuH,ZhaoQ,HeY,NiuJ,DebnathAK,WuS,JiangS.TheaflavinderivativesinblackteaandcatechinderivativesingreenteainhibitHIV-1entrybytargetinggp41.BiochimicaetBiophysicaActa-generalsubjects,2005;1723(1-3):270-281
45.LiuSW,XiaoGF,ChenYB,HeYX,NiuJK,EscalanteCR,XiongHB,FarmarJ,DebnathAK,TienP,JiangSB.Interactionbetweentheheptadrepeat1and2regionsinspikeproteinofSARS-associatedcoronavirus:Implicationforvirusfusogenicmechanismandidentificationoffusioninhibitors.Lancet,2004;363(9413):938-947
46.LiuSW,JiangSB.HighthroughputscreeningandcharacterizationofHIV-1entryinhibitorstargetinggp41:theoriesandtechniques.CurrentPharmaceuticalDesign,2004;10(15):1827-1843
47.LiuSW,ZhaoQ,JiangS.DeterminationoftheHIV-1gp41fusogeniccoreconformationmodeledbysyntheticpeptides:applicableforidentificationofHIV-1fusioninhibitors.Peptides,2003;24(9):1303-1313
48.LiuSW,Boyer-ChatenetL,LuH,JiangS.Rapidandautomatedfluorescence-linkedimmunosorbentassayforhighthroughputscreeningofHIV-1fusioninhibitorstargetinggp41.JournalofBiomolecularScreening,2003;8(6):685-693
49.LiuSW,JiangS,WuZ,LvL,ZhangJ,ZhuZ,WuS.IdentificationofaninhibitoroftheHIV-1gp41six-helixbundleformationfromextractsofChinesemedicalherbsPrunellaVulgarisandRhizomaCibotte.LifeSciences,2002;71:1779-1791
50.LiuSW,LuH,ZhaoQ,HeY,NiuJ,DebnathAK,WuS,JiangS.TheaflavinderivativesinblackteaandcatechinderivativesingreenteainhibitHIV-1entrybytargetinggp41.BiochimicaetBiophysicaActa-generalsubjects,2005;1723(1-3):270-281
51.LiuSW,XiaoGF,ChenYB,HeYX,NiuJK,EscalanteCR,XiongHB,FarmarJ,DebnathAK,TienP,JiangSB.Interactionbetweentheheptadrepeat1and2regionsinspikeproteinofSARS-associatedcoronavirus:Implicationforvirusfusogenicmechanismandidentificationoffusioninhibitors.Lancet,2004;363(9413):938-947
52.LiuSW,JiangSB.HighthroughputscreeningandcharacterizationofHIV-1entryinhibitorstargetinggp41:theoriesandtechniques.CurrentPharmaceuticalDesign,2004;10(15):1827-1843
53.LiuSW,ZhaoQ,JiangS.DeterminationoftheHIV-1gp41fusogeniccoreconformationmodeledbysyntheticpeptides:applicableforidentificationofHIV-1fusioninhibitors.Peptides,2003;24(9):1303-1313
54.LiuSW,Boyer-ChatenetL,LuH,JiangS.Rapidandautomatedfluorescence-linkedimmunosorbentassayforhighthroughputscreeningofHIV-1fusioninhibitorstargetinggp41.JournalofBiomolecularScreening,2003;8(6):685-693
55.LiuSW,JiangS,WuZ,LvL,ZhangJ,ZhuZ,WuS.IdentificationofaninhibitoroftheHIV-1gp41six-helixbundleformationfromextractsofChinesemedicalherbsPrunellaVulgarisandRhizomaCibotte.LifeSciences,2002;71:1779-1791
京公网安备 11010802027423号